Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02935660 · ClinicalTrials.gov registry record · NA
Multi-Wavelength Laser Tattoo Removal Pivotal Study
A NA study, sponsored by Cutera.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT02935660: Completed NA study, sponsored by Cutera.
NCT02935660 is a NA study that has completed, run by Cutera. The registered enrollment target is 27 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02935660, a NA study, has completed, sponsored by Cutera.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
Multi-center study to evaluate the safety and efficacy of an investigational version of the Cutera enlighten laser that offers multiple wavelengths for tattoo removal
Primary Outcome
Percentage of subjects with tattoo ink clearing of at least 50% or more at 6 weeks post-final treatment
Interventions
- DEVICE enLighten Laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2016-10 |
| Est. Completion | 2017-06 |
| Phase | NA |
What the finished NCT02935660 record still lists
NCT02935660 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which enLighten Laser is the first listed.
NCT02935660 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02935660 about?
NCT02935660 is a clinical study titled "Multi-Wavelength Laser Tattoo Removal Pivotal Study". Multi-center study to evaluate the safety and efficacy of an investigational version of the Cutera enlighten laser that offers multiple wavelengths for tattoo removal
What is the current status of trial NCT02935660?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2016-10. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02935660?
The interventions under investigation include: enLighten Laser (DEVICE).
Who is sponsoring clinical trial NCT02935660?
This trial is sponsored by Cutera, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02935660's enrollment target sits among peer trials
27 1708th of 2000 higher than 291 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia